Mounjaro
Signals mentioning Mounjaro
- Tata Consumer readies nutrition products for India’s GLP-1 weight-loss drug users
- Cipla prioritises Yurpeak as sales nearly double, delaying semaglutide launch
- Cipla’s India sales rise 12% as it leans on consumer-health expansion
- Dove's Real Beauty playbook collides with the Ozempic era